FDA declines to endorse leucovorin for autism, walking back earlier statements suggesting benefit
- Posted on March 10, 2026
- By CNN
- 4 Views
FDA declines to endorse leucovorin for autism, walking back earlier statements suggesting benefit
The prescription drug leucovorin is getting a label update, though it’s not what that the US Food and Drug Administration suggested might be coming during a White House briefing in September, when officials touted the drug as a potential treatment for thousands of children with autism.
